Available anytime, anywhere using only your smartphone and a low cost wearable chest belt
The high quality of the ECG recording was verified by cardiologists in a clinical study.
Connects you to your cardiologist and speeds diagnosis
With Kardi AI, we aim to offer medical grade cardiac home monitoring for a low cost by utilizing AI to achieve ECG level performance from a low-cost wearable that is available to the patient any time they need it. The Kardi-AI kit will be available from your cardiologist containing all you'll need to have at home, cardiac monitoring whenever you need. Kardi-AI's artificial neural network will monitor and diagnose your heart every day, letting you know if you should contact your doctor or go to the emergency room.
Unrecognized atrial fibrillation is associated with great healthrisks. Thanks to MyKARDI, if undiagnosed atrial fibrillation is detected, I am alerted withoutdelay and can start treatment adequately. I am convinced that in this way we can avoid thedevelopment of stroke or the slow onset of arrhythmia-related early dementia in many ofmy patients.
Many of my patients do not have easy access to ECG recordings at the time of trouble despite routine check-ups in a cardiology out-patient department and repeated Holter ECG monitoring. MyKARDI allows patients to be able to record an ECG recording at any time, which is then available to me in its entirety. This gives my patients better care than they had before.
The MyKARDI ECG monitoring chest-belts perfectly fill a significant gap in standard ECG monitoring methods for screening atrial fibrillation. There is no doubt that with their help we can prevent cardioembolic strokes in many of our patients.
In majority of patients after catheter ablation of atrial fibrillation, it is practically impossible to monitor them over a long period to be sure we got rid of atrial fibrillation. More available monitoring options could have a huge impact on their treatment.
Learn more about the investors that have backed Kardi AI.
BrightCap Ventures is an early-stage venture capital firm investing in companies with defensible technology and significant global growth potential. Headquartered in Sofia, BrightCap deploys an extended network in Silicon Valley and Europe to assist its portfolio. The firm seeks to invest in small and medium-sized companies working in the sectors of artificial intelligence, big data, medical technology, blockchain, and technologies for the financial sector.
DEPO Ventures is an angel network and VC (Grouport and DEPO Angels Fund II), which connects the world of startups and investors. Depo Ventures is behind the first angel fund of its kind in the Czech Republic; when six years ago, they collected 35 million crowns from investors in the form of experienced managers and other company founders and they gradually invested in fourteen startups under the name Grouport Ventures, such as Tatum, SmartGuide, Mileus or Oxus.AI.